Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-22

Clinical Trial Update: Efficacy and Safety of TPN171H in the Patients With Erectile Dysfunction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial results summarize efficacy and safety of TPN171H in erectile dysfunction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TPN171H

Snippet

Sponsor: Vigonvita Life Sciences | Conditions: Erectile Dysfunction | Phase 2 | Status: COMPLETED